Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.23M Buy
2,526,145
+2,514,158
+20,974% +$3.54M 0.02% 635
2026
Q1
$17.9K Buy
+11,987
New +$18.2K ﹤0.01% 1475
2025
Q4
Sell
-47,035
Closed -$64.4K 1718
2025
Q3
$64.4K Buy
+47,035
New +$62.6K ﹤0.01% 1452
2025
Q1
Sell
-106,441
Closed -$377K 1659
2024
Q4
$377K Buy
+106,441
New +$425K ﹤0.01% 1221
2023
Q4
Sell
-128,434
Closed -$272K 1679
2023
Q3
$272K Buy
+128,434
New +$349K ﹤0.01% 1444
2023
Q1
Sell
-134,536
Closed -$326K 1885
2022
Q4
$326K Buy
+134,536
New +$301K ﹤0.01% 1327
2022
Q3
Sell
-36,130
Closed -$56K 2034
2022
Q2
$56K Buy
+36,130
New +$51K ﹤0.01% 1792
2022
Q1
Sell
-93,530
Closed -$114K 2351
2021
Q4
$114K Buy
93,530
+2,583
+3% +$3.7K ﹤0.01% 1935
2021
Q3
$125K Buy
90,947
+24,917
+38% +$33.3K ﹤0.01% 1880
2021
Q2
$93K Buy
66,030
+13,800
+26% +$20.1K ﹤0.01% 2152
2021
Q1
$83K Buy
52,230
+4,300
+9% +$7.68K ﹤0.01% 1998
2020
Q4
$76K Buy
47,930
+15,688
+49% +$28.6K ﹤0.01% 1857
2020
Q3
$56K Buy
+32,242
New +$59.6K ﹤0.01% 1630

Other funds holding GERN

Michael Gelband's GERN Position: Q2 2026 in Review

Michael Gelband increased its Geron (GERN) stake by 20,974% in Q2 2026, buying an estimated $3.54M and bringing the position to 2,526,145 shares worth $3.23M. The position accounts for 0.02% of the portfolio, ranked #635.

Michael Gelband first reported a position in GERN in Q3 2020 and has held it in 13 quarters since. 258 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Michael Gelband held 2,526,145 shares of Geron worth $3.23M as of Q2 2026.
  • Michael Gelband bought 2,514,158 Geron shares in Q2 2026, an estimated $3.54M.
  • Geron made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #635 holding.
  • Michael Gelband first reported a position in Geron in Q3 2020 and has held it in 13 quarters since.
  • 258 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.